CLINICAL_TRIALS
trial_result
· 2017-07-02
Clinical Trial Update: Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) [Phase 2]
Summary
A Phase 2 trial evaluating retinal pigment epithelium autoimmunity in age-related macular degeneration has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Lawrence S. Morse, MD | Conditions: Age Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02